← All trials
NCT06479863
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 8, 2024
- Primary completion
- May 30, 2027
- Completion date
- Aug 30, 2027
- First posted
- Jun 28, 2024
- Last posted
- Nov 14, 2024
- Enrollment
- 10
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Austin Neuromuscular CenterLead sponsor
- Austin Neuromuscular CenterOfficial
- RegeneronCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.